Medical News

RSS

Breast symmetry can be early indicator of breast cancer

Healthy Women who go on to develop breast cancer tend to have less symmetrical breasts than those women who do not develop the disease, researchers at the University of Liverpool have found.

21 Mar 2006

Environmental chemicals implicated in cancer

New research at the University of Liverpool suggests that environmental contaminants, such as pesticides, are more influential in causing cancer than previously thought.

21 Mar 2006

Zoologists succeed for the first time in transforming stem cells in freshwater polyps

Stem cells are versatile all-rounders. In the medical field, high hopes are resting on these miracle workers. However, we still understand very little about them.

21 Mar 2006

Combining old with new could resolve fertility problems

Many women with fertility problems could have a significantly better chance of having a baby if modern IVF techniques are combined with more traditional surgical interventions, according to a leading fertility specialist.

From Sheffield Hallam University 21 Mar 2006

Angina is more dangerous for women than was previously thought

The collaborative study, led by UCL (University College London) and funded by the British Heart Foundation, found that angina in women is as common as it is in men, in contrast to heart attacks (myocardial infarction) which have a higher rate in men.

21 Mar 2006

Swedish scientists move closer to a cancer vaccine

Scientists at Karolinska Institutet in Sweden have helped to identify a molecule that can be used as a vaccination agent against growing cancer tumours. Although the results are so far based on animal experiments, they point to new methods of treating metastases.

21 Mar 2006

New discovery explains how a common gene variant may increase cancer risks

Roughly 15 percent of the population carries a gene variant that may increase the risk of developing cancer. The cause of this increased risk has been unknown until now. But now a research team at Stockholm University in Sweden can explain why.

21 Mar 2006

The role of evolutionary genomics in the development of autism

Scientists at the London School of Economics, UK and Simon Fraser University, Canada have described the first hypothesis grounded in evolutionary genomics explaining the development of autism.

21 Mar 2006

Study uncovers variations in service on UK's psychiatric wards

A groundbreaking study to assess the state of the nation’s acute psychiatric wards has uncovered substantial variations in service provision and delivery.

21 Mar 2006

Smokefree bars policy in New Zealand shows economic and health benefits

The introduction of a smokefree law in bars and restaurants in New Zealand has had positive health and economic impacts.

21 Mar 2006

Gene discovered that causes dry skin and leads to eczema and asthma

Experts, lead by the University of Dundee, have discovered the gene which causes genetic skin conditions affecting millions of people.

21 Mar 2006

Multinationals preparing for Avian flu across the globe

Multinational companies are taking steps in many parts of the world to plan for the possibility of an avian flu outbreak, a new survey by Watson Wyatt Worldwide, a global human capital firm, has found.

21 Mar 2006

U.S. screening for highly pathogenic H5N1 avian influenza in migratory birds

Secretary of Agriculture Mike Johanns, Secretary of the Interior Gale A. Norton and Secretary of Health and Human Services Michael Leavitt have moved to further ensure the protection of people, domestic poultry and wild birds by unveiling an enhanced national framework for early detection of highly pathogenic avian influenza (HPAI) in wild migratory birds in the United States.

21 Mar 2006

ChemGenex Pharmaceuticals receives U.S. orphan drug designation for Ceflatonin

ChemGenex Pharmaceuticals has announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug status for the company's most advanced drug, Ceflatonin, for the treatment of chronic myeloid leukemia (CML).

21 Mar 2006

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).

21 Mar 2006